Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Chinese Patent Office
Federal Trade Commission
Accenture
Teva
McKesson
Express Scripts
Cipla

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,711,880

« Back to Dashboard

Summary for Patent: 4,711,880
Title: Crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
Abstract:The invention relates to a novel crystal modification, containing water of crystallization, of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate of the formula ##STR1## and to a process for the manufacture thereof. This modification is suitable for the oral treatment of disorders of the calcium and phosphate metabolism and associated diseases in warm-blooded animals.
Inventor(s): Stahl; Peter H. (Freiburg, DE), Schmitz; Beat (Allschwil, CH)
Assignee: Ciba-Geigy Corporation (Ardsley, NY) Henkel Kommanditgesellschaft auf Aktien (Dusseldorf-Holthausen, DE)
Application Number:06/905,097
Patent Claim Types:
see list of patent claims
Compound; Formulation;

Drugs Protected by US Patent 4,711,880

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,711,880

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland3768/84Aug 06, 1984

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Department of Justice
Cantor Fitzgerald
Chinese Patent Office
QuintilesIMS
Argus Health
Mallinckrodt
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.